Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial

Author(s):
Hirsch, A.; Nijveldt, R.; Vleuten, P.A. van der; Tijssen, J.G.P.; Giessen, W.J. van der; Tio, R.A.; Waltenberger, J.; Berg, J.M. ten; Doevendans, P.A.; Aengevaeren, W.R.M.; Zwaginga, J.J.; Biemond, B.J.; Rossum, A.C. van; Piek, J.J.; Zijlstra, F.; HEBE Investigators
Published
2011
Publication type
Article / Letter to editor
Cell therapyMyocardial infarctionMagnetic resonance imagingLeft ventricular functionRemodelling
Date issued
2011-07-31
Language
English
Is part of
European Heart Journal (2011), Vol. 32, no. 14, p. 1736-1747
hdl
1887/108528
doi
10.1093/eurheartj/ehq449